Oral anticoagulation in chronic kidney disease with atrial fibrillation
Chronic kidney disease (CKD) and atrial fibrillation (AF) frequently coexist, amplifying the risk of cardiovascular events and mortality. In patients with CKD stage 3 and non-valvular AF, direct oral anticoagulants (DOACs) have shown, compared to vitamin K antagonists (VKA), equal or greater efficac...
Main Authors: | Pablo Gomez -Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251421000365 |
Similar Items
-
Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
by: Carmen Sánchez-González, et al.
Published: (2022-11-01) -
Nuevos anticoagulantes orales en pacientes con enfermedad renal crónica
by: Lara Belmar Vega, et al.
Published: (2017-05-01) -
EFECTIVIDAD Y SEGURIDAD DEL TRATAMIENTO CON ANTICOAGULANTES ORALES NO ANTAGONISTAS DE LA VITAMINA K (NOAC) EN FIBRILACIÓN AURICULAR
by: Silvia Aracelly Proaño Lucero, et al.
Published: (2023-11-01) -
NUEVOS ANTICOAGULANTES ORALES EN FIBRILACIÓN AURICULAR
by: Dra. E. Marianella Seguel R.
Published: (2015-03-01) -
Patrón tromboelastográfico en pacientes anticoagulados con rivaroxabán por fibrilación auricular
by: Susana Pacheco Jaramillo, et al.
Published: (2016-11-01)